Scholarlink

Background <p>Metabolic syndrome (MetS) is a set of symptoms, including insulin resistance, high blood sugar, and abdominal obesity, that increases the risk of cardiovascular diseases. This syndrome is prevalent in acute coronary syndrome (ACS), comprising patients with acute myocardial infarction (AMI). This study evaluated the prognosis of AMI patients who underwent primary PCI in two groups with and without MetS.</p> Methods <p>This retrospective study was performed on ST-segment elevation myocardial infarction (STEMI) patients referred to the emergency department of Tehran Heart Center from 2012 to 2020 who underwent primary PCI. Patients were divided into MetS and non-MetS according to the International Diabetes Federation (IDF) criteria. Clinical and laboratory characteristics were compared between the two groups.</p> Results <p>Two thousand, six hundred fifty-one patients were included, and 1850 patients (70%) had MetS. The mean age of patients with MetS compared to non-MetS showed no significant difference (60.16 vs 59.37 years, <i>P-</i>value = 0.053). In both groups, the majority were men. Forty-seven in-hospital deaths occurred, with no significant difference regarding the presence of MetS. Two hundred-six deaths happened during the one-year follow-up, without a significant difference between the two groups. Two hundred-sixteen MACEs were observed in one year, which was not significantly different between patients with and without MetS.</p> Conclusion <p>In-hospital mortality, one-year death, and one-year MACCE were not associated with MetS in this study.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of metabolic syndrome on clinical characteristics and one-year outcomes of patients undergoing primary percutaneous coronary intervention: a propensity score-matched comparison

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月1日

查看全文
  • Babak Geraiely,
  • Elnaz Shahmohamadi,
  • Mohammad Javad Zare Nejad,
  • Alireza Barzegary,
  • Farnoosh Larti,
  • Ahmad Vakili-Basir,
  • Ali Mohammad Haji Zeinali

摘要

Background

Metabolic syndrome (MetS) is a set of symptoms, including insulin resistance, high blood sugar, and abdominal obesity, that increases the risk of cardiovascular diseases. This syndrome is prevalent in acute coronary syndrome (ACS), comprising patients with acute myocardial infarction (AMI). This study evaluated the prognosis of AMI patients who underwent primary PCI in two groups with and without MetS.

Methods

This retrospective study was performed on ST-segment elevation myocardial infarction (STEMI) patients referred to the emergency department of Tehran Heart Center from 2012 to 2020 who underwent primary PCI. Patients were divided into MetS and non-MetS according to the International Diabetes Federation (IDF) criteria. Clinical and laboratory characteristics were compared between the two groups.

Results

Two thousand, six hundred fifty-one patients were included, and 1850 patients (70%) had MetS. The mean age of patients with MetS compared to non-MetS showed no significant difference (60.16 vs 59.37 years, P-value = 0.053). In both groups, the majority were men. Forty-seven in-hospital deaths occurred, with no significant difference regarding the presence of MetS. Two hundred-six deaths happened during the one-year follow-up, without a significant difference between the two groups. Two hundred-sixteen MACEs were observed in one year, which was not significantly different between patients with and without MetS.

Conclusion

In-hospital mortality, one-year death, and one-year MACCE were not associated with MetS in this study.